Who
Robert J. Bitterman
Chairman, Pres. & CEO
Company insider
Files Form 4 as: Chairman, Pres. & CEO, Phio Pharmaceuticals.
In numbers
- Trades disclosed
- 60
- Buys
- 25
- Sells
- 0
- Bought
- $116K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 7 Jun 2013
- Last trade
- 28 Sep 2026
- Last filed
- 29 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Sep 2026filed 29 Sep 2026 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —400,000 at $0.00 | filing |
| 28 Sep 2026filed 29 Sep 2026 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —400,000 at $0.00 | filing |
| 22 Sep 2026filed 23 Sep 2026 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $2,0582,000 at $1.03 | filing |
| 22 Sep 2026filed 23 Sep 2026 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $2,0602,000 at $1.03 | filing |
| 11 Sep 2026filed 15 Sep 2026 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $71K68,550 at $1.03 | filing |
| 11 Sep 2026filed 15 Sep 2026 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $71K68,550 at $1.03 | filing |
| 18 Aug 2026filed 19 Aug 2026 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $11K10,000 at $1.06 | filing |
| 18 Aug 2026filed 19 Aug 2026 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $11K10,000 at $1.06 | filing |
| 26 Jun 2026filed 29 Jun 2026 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $9,90010,000 at $0.99 | filing |
| 26 Jun 2026filed 29 Jun 2026 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $9,90010,000 at $0.99 | filing |
| 5 Feb 2026filed 6 Feb 2026 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —120,000 at $0.00 | filing |
| 5 Feb 2026filed 6 Feb 2026 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —120,000 at $0.00 | filing |
| 31 Dec 2025filed 2 Jan 2026 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $5,1505,000 at $1.03 | filing |
| 31 Dec 2025filed 2 Jan 2026 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $5,1505,000 at $1.03 | filing |
| 23 Dec 2025filed 29 Dec 2025 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $5,1005,000 at $1.02 | filing |
| 21 Nov 2025filed 24 Nov 2025 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $5,7005,000 at $1.14 | filing |
| 18 Nov 2025filed 19 Nov 2025 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $6,3505,000 at $1.27 | filing |
| 11 Sep 2025filed 15 Sep 2025 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $9,5384,111 at $2.32 | filing |
| 11 Sep 2025filed 15 Sep 2025 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 10 Jun 2025filed 11 Jun 2025 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $4,8402,000 at $2.42 | filing |
News
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow SeriesPHIO · standard-freeholder.com · 19 Oct 2026
0 headlines in the last 90 days name Robert J. Bitterman; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.